Label-free metabolic imaging of non-alcoholic-fatty-liver-disease (NAFLD) liver by volumetric dynamic optical coherence tomography.
Pradipta MukherjeeShinichi FukudaDonny LukmantoToshiharu YamashitaKosuke OkadaShuichi MakitaIbrahim Abd El-SadekArata MiyazawaLida ZhuRion MorishitaAntonia LichteneggerTetsuro OshikaYoshiaki YasunoPublished in: Biomedical optics express (2022)
Label-free metabolic imaging of non-alcoholic fatty liver disease (NAFLD) mouse liver is demonstrated ex vivo by dynamic optical coherence tomography (OCT). The NAFLD mouse is a methionine choline-deficient (MCD)-diet model, and two mice fed the MCD diet for 1 and 2 weeks are involved in addition to a normal-diet mouse. The dynamic OCT is based on repeating raster scan and logarithmic intensity variance (LIV) analysis that enables volumetric metabolic imaging with a standard-speed (50,000 A-lines/s) OCT system. Metabolic domains associated with lipid droplet accumulation and inflammation are clearly visualized three-dimensionally. Particularly, the normal-diet liver exhibits highly metabolic vessel-like structures of peri-vascular hepatic zones. The 1-week MCD-diet liver shows ring-shaped highly metabolic structures formed with lipid droplets. The 2-week MCD-diet liver exhibits fragmented vessel-like structures associated with inflammation. These results imply that volumetric LIV imaging is useful for visualizing and assessing NAFLD abnormalities.
Keyphrases
- optical coherence tomography
- high resolution
- label free
- physical activity
- weight loss
- diabetic retinopathy
- oxidative stress
- randomized controlled trial
- type diabetes
- computed tomography
- high throughput
- magnetic resonance imaging
- adipose tissue
- metabolic syndrome
- single cell
- insulin resistance
- mass spectrometry
- photodynamic therapy
- skeletal muscle
- high fat diet induced
- placebo controlled